Ghent University Academic Bibliography

TRPS1 is consistently expressed in hidradenoma papilliferum

Lars Velthof (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , David Creytens (UGent) and Koen Van de Vijver (UGent)

(2025) INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 44(2). p.99-103

Add to list

Journal Article
A1
open access

Aflatoxin B1 and Epstein-Barr virus- induced CCL22 expression stimulates B cell infection

Mohamed Ali Maroui, Grace Akinyi Odongo, Lucia Mundo, Francesca Manara, Fabrice Mure, Floriane Fusil, Antonin Jay, Tarik Gheit, Thanos Mouchtaris-Michailidis (UGent) , Domenico Ferrara, et al.

(2024) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(16).

Add to list

Journal Article
A1
open access

Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery

Axel Van Damme, Philippe Tummers (UGent) , Pieter De Visschere (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Tom Vercauteren (UGent) , Werner De Gersem (UGent) , Hannelore Denys (UGent) , Eline Naert (UGent) , Amin Makar (UGent) , et al.

(2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 47.

Add to list

CD4+T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy

Amelie Franken, Michel Bila, Aurelie Mechels, Sam Kint (UGent) , Jeroen Van Dessel, Valentina Pomella, Sebastiaan Vanuytven, Gino Philips, Orian Bricard, Jieyi Xiong, et al.

(2024) IMMUNITY. 57(3). p.541-558.e7

Add to list

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Emiel De Jaeghere (UGent) , Hannelore Hamerlinck (UGent) , Sandra Tuyaerts, Lien Lippens (UGent) , An M.T. Van Nuffel, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2024) GYNECOLOGIC ONCOLOGY. 191. p.275-286

Add to list

Journal Article
A1
open access

Propensity weighting plus adjustment in proportional hazards model is not doubly robust

Erin E. Gabriel, Michael C. Sachs, Ingeborg Waernbaum, Els Goetghebeur (UGent) , Paul F. Blanche, Stijn Vansteelandt (UGent) , Arvid Sjölander and Thomas Scheike

(2024) BIOMETRICS. 80(3).

Add to list

Journal Article
A1
open access

Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer

Menekse GOKER (UGent) , Hannelore Denys (UGent) , An Hendrix (UGent) , Olivier De Wever (UGent) , Koen Van de Vijver (UGent) and Geert Braems (UGent)

(2023) BREAST CANCER RESEARCH. 25(1).

Add to list

Journal Article
A1
open access

Microbial sophorolipids inhibit colorectal tumour cell growth in vitro and restore haematocrit in Apcmin+/− mice

Breedge Callaghan, Matthew S. Twigg, Niki Baccile, Inge Van Bogaert (UGent) , Roger Marchant, Christopher A. Mitchell and Ibrahim M. Banat

(2022) APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. 106(18). p.6003-6016

Add to list

Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum

Ellen Deolet (UGent) , Iteeka Arora, Jo Van Dorpe (UGent) , Joni Van der Meulen (UGent) , Sudha Desai, Nadine Van Roy (UGent) , Baljeet Kaur, Koen Van de Vijver (UGent) and W Glenn McCluggage

(2022) AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 46(1). p.124-133

Add to list

Journal Article
A1
open access

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles

Rahul Bhome, Muhammad Emaduddin, Victoria James, Louise M. House, Stephen M. Thirdborough, Massimiliano Mellone, Joeri Tulkens, John N. Primrose, Gareth J. Thomas, Olivier De Wever (UGent) , et al.

(2022) JOURNAL OF EXTRACELLULAR VESICLES. 11(5).

Academic Bibliography

TRPS1 is consistently expressed in hidradenoma papilliferum

Aflatoxin B1 and Epstein-Barr virus- induced CCL22 expression stimulates B cell infection

Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery

CD4+T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Propensity weighting plus adjustment in proportional hazards model is not doubly robust

Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer

Microbial sophorolipids inhibit colorectal tumour cell growth in vitro and restore haematocrit in Apcmin+/− mice

Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles

Contents

Support

Contact